Skip to main content

Table 2 Primary response analysis

From: Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

Trial Number

Scan 1 (week 6)

Scan 2

Scan 3

Scan 4

Scan 5

A1

PD

    

A2

PD

    

B2

SD

SD

SD

SD

PD

C2

SD

SD

PD

  

C3

PD

    
  1. PD progressive disease
  2. SD stable disease